The Changing View Regarding GMOs

  • Kellow, Aynsley. “Risk Assessment and Decision-Making for Genetically Modified Foods.” Risk: Health, Safety & Environment, vol. 13, no. 1/2, 2002, pp. 115–135. Supplemental Index, http://eds.b.ebscohost.com/eds/detail/detail?vid=2&sid=1cc1d394-9ad4-49d...

    (The exact date was not given; the article states Spring 2002). This journal article states that GMOs need to be tested and that society needs to determine whether the pros of GMOs are greater than the cons. While the article mentions the possible risks, the article seems to focus on the potential positive aspects of GMOs.
  • Renault, Pierre. “Genetically Modified Lactic Acid Bacteria: Applications to Food or Health and Risk Assessment.” Biochimie, vol. 84, no. 11, 1 Nov. 2002, pp. 1073–1087. Elsevier, doi:10.1016/S0300-9084(02)00029-9. Accessed 28 Sept. 2016.

    Reviewing the uses for genetically modified lactic acid bacteria, Renault describes the uses and benefits of this bacteria. He explains that more tests should be performed to determine the safety of the bacteria.
  • Celec, Peter et al. “Biological and Biomedical Aspects of Genetically Modified Food.” Biomedicine & Pharmacotherapy, vol. 59, no. 10, 21 Oct. 2005, pp. 531–540. Elsevier, doi:10.1016/j.biopha.2005.07.013. Accessed 17 Sept. 2016.

    Examining the potential uses for GMOs, Celec takes a positive outlook on the possible benefits while explaining they should be regulated. Overall, he recommends looking for applications for GMOs.
  • Domingo, José L, and Jordi Giné Bordonaba. “A Literature Review on the Safety Assessment of Genetically Modified Plants.” Environment International, vol. 37, no. 4, May 2011, pp. 734–742. Elsevier, doi:10.1016/j.envint.2011.01.003. Accessed 28 Sept. 2016.

    Detailing the risks of human consumption of GMOs, Domingo and Barbonaba write their article as concerns regarding the safety of GMOs begin to arise in society.
  • Krimsky, Sheldon. “An Illusory Consensus behind GMO Health Assessment.” Science, Technology & Human Values, vol. 40, no. 6, Nov. 2015, pp. 883–914. Sage, doi:10.1177/0162243915598381. Accessed 17 Sept. 2016.

    Conducting a risk assessment on GMOs, Krimsky concludes by suggesting that more research should be completed. Even though there are few articles concluding that GMOs are not safe, those studies should be replicated to prove or disprove their claims.
  • Schubert, David. “Science Supports the Need for GM Food Labeling.” GeneWatch, vol. 29, no. 1, Jan. 2016, pp. 6–9. Academic Search Premier [EBSCO], http://eds.b.ebscohost.com/eds/detail/detail?sid=fc5187e8-bcaf-46ed-9c39-4e5bb3911648%40sessionmgr104&vid...

    Taking a negative stance towards GMOs, Schubert determines through analyzing his evidence that due to the lack of research regarding the benefits of GMOs that clinical trials need to be performed. Furthermore, GMOs should be labeled because their safety status has not been confirmed; therefore, GMOs should be treated as detrimental until proven otherwise. This allows the public to make their own decision on whether or not to buy GMO products.